Absorption rate: Though slower than IV and IM, absorption rate still performs well over time
Bupropion lowers seizure threshold and is contraindicated in patients with seizure disorders, eating disorders, or during abrupt alcohol or benzodiazepine withdrawal
The earliest biosimilar applicants filed 351(k) applications well in advance of that date (since development takes several years), and the market should expect first biosimilar approvals around 2027-2028, with commercial launch timelines dependent on Patent Dance litigation resolution or settlement
Retrieved from Loomba, R., Abdelmalek, M
245lbs We estimate you could lose up to:54 lbs *Projection based on average results from patient feedback
No Membership Fees No Insurance Required